• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Post-partum Implanon offers long-term contraception for high risk women

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
May 18, 2014
in Obstetrics
Reading Time: 2 mins read
Clinic intervention reduces pregnancy risk behaviors in vulnerable youth
Share on FacebookShare on Twitter

Image: PD 

1. Two-thirds of women who had an implanon placed immediately post-partum used the birth control method for the entirety of its 3-year lifespan. 

2. Continuation rates were higher in women at highest risk for recurrent pregnancy, including adolescents and those with poor prenatal care. 

Evidence Rating Level: 2 (Good)           

Study Rundown: This study found that the continuation rate for women who received an implanon, a 3-year long-acting reversible contraceptive method (LARC), immediately post-partum was over 66% at 3 years. Compliance rates were even higher in women who were most at risk for recurrent pregnancy, including adolescents and those with poor prenatal care. This is the first study to include behavioral variables, such as number of prenatal care visits, in the evaluation of characteristics associated with contraceptive continuation. One strength of this study is a high follow-up rate (>70%). Limitations include a relatively small sample size and lack of a control group. Future studies might try to replicate findings with a larger, multi-centered cohort and compare continuation rates between women who received post-partum implanon with other non-LARC methods.

Click to read the study in Contraception

RELATED REPORTS

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

Relevant Reading: Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?

In-Depth [retrospective cohort]: Researchers collected data from electronic medical records for all women at an urban, academic medical center who had an etonogestrel contraceptive implant (Implanon) placed immediately postpartum between January 2008 and March 2009. The primary outcome was continuation rates at 1, 2, and 3 years (the lifetime of the implant). Secondary outcomes included characteristics of women who had the Implanon placed and adverse effects that led to early discontinuation. Of the 262 women, 28.2% were adolescents, 71.8% were multigravid and 38.5% had poor prenatal care (<6 prenatal visits).

The overall continuation rate of implanon at 3 years was 66.3%. 94.5% of adolescents and 94.1% of women with poor prenatal care (<6 visits) retained their Implanon at 1 year, as compared with 87% overall. The most common reason for discontinuation was abnormal bleeding (41%) followed by weight gain (19%).

More from this author: In elderly, robotic surgery for endometrial cancer linked with lower morbidity, Individualized pelvic floor muscle training improves prolapse symptoms, Knowledge gaps regarding fertility prevalent in reproductive aged women, IUD contraception equally safe in teenagers as in older women 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: contraceptionimplanon
Previous Post

Decreased HIV co-receptor CCR5 expression after IUD insertion

Next Post

The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Endocrinology

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

July 30, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

April 16, 2024
1 in 5 US women report delayed contraceptive initiation after sexual debut
Emergency

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

September 27, 2023
AAP policy update recommends first-line contraceptives, addresses special populations
Emergency

Postpartum patients may be at an increased risk of intrauterine device-related perforation

June 15, 2022
Next Post
Maternal vitamin D status does not affect offspring’s bone-mineral content

The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients

High BMI linked to reduced risk of endometriosis

Decreased sleep in childhood linked to later central adiposity

Pro-vaccine messages not associated with increased vaccination intent

Robust hepatitis B seroprotection in adolescence after immunization in infancy

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.